Walleye Trading LLC Intercept Pharmaceuticals, Inc. Transaction History

Walleye Trading LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$13.37 - $17.79 $202,622 - $269,607	-15,155 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $176,100 - $240,843	12,332 Added 436.84%	15,155 $247,000
Q3 2021 Nov 15, 2021	SELL	$12.99 - $20.47 $104,972 - $165,418	-8,081 Reduced 74.11%	2,823 $42,000
Q1 2021 May 17, 2021	BUY	$19.33 - $37.75 $16,623 - $32,465	860 Added 8.56%	10,904 $252,000
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $245,877 - $426,568	10,044 New	10,044 $248,000

Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $23,256 - $45,835	-498 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$48.35 - $118.68 $12,522 - $30,738	259 Added 108.37%	498 $31,000
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $13,709 - $29,659	239 New	239 $30,000
Q2 2019 Aug 14, 2019	SELL	$77.77 - $120.68 $186,803 - $289,873	-2,402 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $220,575 - $289,873	2,402 New	2,402 $269,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.